National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

Found 2,731 cases where Vaccine targets COVID-19 (COVID19) and Manufacturer is PFIZER/BIONTECH and Symptom is Myocarditis



Case Details

This is page 5 out of 274

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14   next


VAERS ID: 1197826 (history)  
Form: Version 2.0  
Age: 17.0  
Sex: Male  
Location: California  
Vaccinated:2021-04-08
Onset:2021-04-11
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0158 / 2 RL / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Electrocardiogram ST segment elevation, Myocarditis, Pericarditis, Troponin increased
SMQs:, Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Lexapro 10 mg
Current Illness: none
Preexisting Conditions: Obesity, anxiety, depression
Allergies: none
Diagnostic Lab Data: See item 18.
CDC Split Type:

Write-up: Chest pain developed 3 days following vaccine administration. Presented to ED the morning of 4/11/2021, and was found to have diffuse ST elevation on ECG, and troponin level of 0.52. Received dose of aspirin, and then was transferred to Hospital for treatment and monitoring of pericarditis the afternoon of 4/11. Echo at Hospital with good LV function. Repeat EKG demonstrated ST elevation again, and he was started on ibuprofen 600 mg every 6 hours. Chest pain recurred in the evening of 4/11, but resolved some time after administration of ibuprofen. Troponin level upon arrival to Hospital were 3.92 at 17:11 on 4/11, then rose 8.68 at 23:42 on 4/11 at the time of his worsening chest pain. Chest pain still resolved by morning of 4/12, and troponin level downtrended to 5.87 at 6:22 on 4/12. Diagnosis consistent with myopericarditis.


VAERS ID: 1208348 (history)  
Form: Version 2.0  
Age: 41.0  
Sex: Male  
Location: California  
Vaccinated:2021-03-30
Onset:2021-04-05
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH 6023251 / UNK - / IM

Administered by: Private       Purchased by: ?
Symptoms: Brain natriuretic peptide increased, Electrocardiogram abnormal, Myocarditis, Pyrexia, Troponin increased, Ultrasound scan
SMQs:, Cardiac failure (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: tested positive for COVID vis PCR on 3/10 was asymptomatic
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Echo trop bnp ecg plan for outpatient cardiac MRI
CDC Split Type:

Write-up: mild myocarditis with fevers +constitutional symptoms, trop and BNP elevation (without other cause), ekg abnormalities, EF wl


VAERS ID: 1210297 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Female  
Location: Idaho  
Vaccinated:2021-04-08
Onset:2021-04-11
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6204 / 2 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Acute myocardial infarction, Angiogram pulmonary normal, Atrial fibrillation, Catheterisation cardiac normal, Echocardiogram normal, Injection site pain, Magnetic resonance imaging abnormal, Magnetic resonance imaging heart, Musculoskeletal discomfort, Myocarditis, Oropharyngeal discomfort, Pain, Salivary hypersecretion, Scan with contrast, Troponin increased
SMQs:, Rhabdomyolysis/myopathy (broad), Myocardial infarction (narrow), Supraventricular tachyarrhythmias (narrow), Embolic and thrombotic events, arterial (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Extravasation events (injections, infusions and implants) (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Ibuprofen Tums
Current Illness: No illnesses at the time of vaccination, nor the month prior
Preexisting Conditions: No significant medical history
Allergies: No known, allergies
Diagnostic Lab Data: Cardiac catheterization revealed normal coronaries, with no evidence of onstruction. Echocardiography revealed normal heart anatomy and function. CT Chest with angiography revealed no eveidence of pumonary embolus Troponin continued to rise and reached 6.52 MRI Heart with gadolimium showed evidence of Myocarditis
CDC Split Type:

Write-up: Patient awoke in the middle of the night (1:20am) with severe discomfort in the neck and throat. Excess saliva. As the pain persisted the pain radiated to the left arm/shoulder. We sought help at our local emergency department where she was found to be in new onset atrial fibrillation. A battery of tests were ordered including a troponin which was noted to be: 1.48. She was transported via ambulance to the hospital to be admitted and undergo left heart cardiac catheterization with the presumptive diagnosis of NSTEMI.


VAERS ID: 1214410 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Female  
Location: Nebraska  
Vaccinated:2021-04-10
Onset:2021-04-13
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: C-reactive protein increased, Chest discomfort, Chest pain, Electrocardiogram normal, Influenza virus test negative, Magnetic resonance imaging heart, Myocarditis, Respiratory syncytial virus test negative, Respiratory viral panel, SARS-CoV-2 test negative, Troponin
SMQs:, Anaphylactic reaction (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: levothyroxine loratadine topiramate
Current Illness: between 1st and 2nd covid shots she had dizziness/vertigo for several days which resolved
Preexisting Conditions: hypothyroidism migranes
Allergies: hydrocodone
Diagnostic Lab Data: EKG: NSR With mild nonspecific ST T wave changes troponin peaked at 9.59 on 4/14/21 CRP = 25 on 4/13/21 covid negative 4/14 respiratory pathogen screen negative 4 plex nasal screen, influenza, covid, RSV all negative Cardiac MRI on 4/14/21 report: 1. The left ventricle is normal in cavity size with normal wall thickness, global systolic function is normal with an LVEF at 64%. 2. The right ventricle is normal in cavity size with normal wall thickness, global systolic function is normal with RVEF at 50%. 3. Normal left and right atrium. 4. Delayed contrast enhancement imaging of the left ventricle is abnormal, with evidence of epicardial delayed enhancement in the basal inferolateral wall, with increase in signal in STIR imaging (edema). The prior is most likely consistent with myocarditis. 5. There is no evidence of subendocardial enhancement (myocardial infarction related to coronary artery disease)
CDC Split Type:

Write-up: Myocarditis after 2nd covid shot 27 year old female received her 2nd covid shot on 4/10/21 then presented to the hospital with substernal chest pressure upon waking radiating to the left arm on 4/13/21. No previous cardiac history. test shown below, discharged from hospital on 4/15/21. She was improved, no chest pain at time of discharge.


VAERS ID: 1217884 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Female  
Location: Wisconsin  
Vaccinated:2021-03-17
Onset:2021-03-21
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER2613 / 1 LA / IM

Administered by: Work       Purchased by: ?
Symptoms: Arteriogram carotid, Blood cholesterol normal, Blood magnesium decreased, Blood magnesium normal, Blood potassium decreased, Blood triglycerides increased, C-reactive protein increased, Catheterisation cardiac, Chest pain, Echocardiogram normal, Ejection fraction, Electrocardiogram normal, Feeling abnormal, High density lipoprotein normal, Left ventricular dysfunction, Low density lipoprotein normal, Magnetic resonance imaging abnormal, Magnetic resonance imaging heart, Myocardial oedema, Myocarditis, Nausea, Pain in extremity, Pain in jaw, Red blood cell sedimentation rate increased, Total cholesterol/HDL ratio normal, Troponin increased
SMQs:, Cardiac failure (broad), Acute pancreatitis (broad), Dyslipidaemia (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Myocardial infarction (narrow), Dementia (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Lipodystrophy (broad), Osteonecrosis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypokalaemia (narrow), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ? OMEPRAZOLE PO Take by mouth daily. ? norgestimate-ethinyl estradiol (ORTHO-CYCLEN) 0.25-35 MG-MCG per tablet Take 1 tablet by mouth daily. ? albuterol (VENTOLIN) (2.5 MG/3ML) 0.083% nebulizer solution Inhale 1 vial into the lungs every
Current Illness: None, but did have COVID 19 infection 11/13/2020.
Preexisting Conditions: ? Gastroesophageal reflux disease ? RAD (reactive airway disease) /persistent asthma Seasonal and environmental allergies
Allergies: ? Benadryl Allergy SHORTNESS OF BREATH ? Mold, animal, mites (Environmental) Induces asthma ? Seasonal Other (tree, grass) Induces asthma
Diagnostic Lab Data: 3/30/21 Cardiac MRI-Findings compatible with acute to subacute myocarditis. There is significant dense, patchy, sub epicardial, nonischemic type of delayed enhancement along the entire lateral wall extending into the inferior wall with significant lateral wall myocardial edema. Consider follow-up cardiac MRI in 6 months to reevaluate extent of delayed enhancement after edema has Resolved. Overall mildly reduced left ventricular systolic function. LVEF 51%. RVEF: 51% Background ECV: 21% 3/21/21 Cath: Angiographically normal coronary arteries. No culprit lesion found to explain patient''s elevated troponin. Normal LVEDP. Successful right radial access 3/21/21 Echo: Normal LV size and wall thickness. Normal LV systolic function. LVEF 67%. No wall motion abnormalities. Normal RV size and systolic function. No valve dysfunction 3/21/2021 Initial troponin elevated at 2.97 at 8:30 a.m., 2nd troponin at 10:38 a.m. was elevated at 8.81. Inflammatory markers: Sedimentation rate slightly elevated at 21, C-reactive protein slightly elevated at 3.0 Cholesterol (mg/dL) Date Value 03/22/2021 183 HDL (mg/dL) Date Value 03/22/2021 61 Cholesterol/ HDL Ratio (no units) Date Value 03/22/2021 3.0 Triglycerides (mg/dL) Date Value 03/22/2021 183 (H) LDL (mg/dL) Date Value 03/22/2021 85 MG 1.6 (L) 03/21/2021 MG 1.6 (L) 03/21/2021
CDC Split Type:

Write-up: Woke with up chest, arm and jaw pain on 03/21/2021. Presented to the ED. Her initial EKG was negative for any acute changes but her troponin was elevated. Cardiology was consulted. Her echo was negative for cardiomyopathy or hypertrophy. But after her troponin continued to rise she was taken to the cath lab to look for ischemia. Her cardiac angiography was negative for obstructive disease, and coronary arteries were completely normal. Had low magnesium and potassium- so started on oral supplementation. Discharged on 03/22/2021 with nitroglycerin (which was not helpful and made her feel worse/nauseated) and to follow up with outpatient cardiac MRI and cardiology. This imaging revealed significant myocardial edema consistent with myocarditis. 04/01/2021 Per Cardiology: -Given that the patient had covid 19 back in November 2019 I believe she may have had a low yield subacute myocardial infection at that time that was somehow exacerbated by her 1st covid vaccine. Therefore, after some consideration and careful discussion I am advising against the 2nd vaccine at this time. -No physical exercise for 6 months given her current myocarditis and family hx of sudden cardiac death -May trial PRN NSAIDS for pain relief -Recommend birth control and no pregnancy until at least after her follow up cMRI -Follow up in 6 months with cMRI prior


VAERS ID: 1219312 (history)  
Form: Version 2.0  
Age: 31.0  
Sex: Male  
Location: New Jersey  
Vaccinated:2021-03-28
Onset:2021-03-28
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8733 / 1 RA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Intensive care, Myocardial infarction, Myocarditis
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: 3 days later I was in the hospital with a heart attack. I was in CCU for 3 days. The muscle above my heart was inflamed and caused my heart not to do it?s job. I had tests run on my heart and my body and all conclusions came to the vaccine.


VAERS ID: 1221001 (history)  
Form: Version 2.0  
Age: 22.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-04-07
Onset:2021-04-09
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Myocarditis, Troponin increased
SMQs:, Myocardial infarction (narrow), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: troponin level to 26
CDC Split Type:

Write-up: Myocarditis with a troponin level to 26.


VAERS ID: 1224211 (history)  
Form: Version 2.0  
Age: 19.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-04-09
Onset:2021-04-16
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Electrocardiogram abnormal, Myocarditis, Pericarditis, Troponin increased
SMQs:, Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: None
Allergies: NKDA
Diagnostic Lab Data: Elevated troponin, abnormal EKG - 4/17/2021; additional workup still pending at this time
CDC Split Type:

Write-up: admitted to hospital with chest pain, elevated troponin with clinical exam consistent with myocarditis/pericarditis. No known past medical history, no recent upper respiratory / GI illness preceding admission


VAERS ID: 1224441 (history)  
Form: Version 2.0  
Age: 43.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2021-03-09
Onset:2021-03-27
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6202 / 2 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Myocarditis, SARS-CoV-2 test negative, Troponin, Troponin increased
SMQs:, Myocardial infarction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: METOPROLOL TARTRATE; VITAMIN D NOS
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: High Blood Pressure
Allergies:
Diagnostic Lab Data: Test Date: 20210329; Test Name: Nasal Swab; Test Result: Negative ; Test Date: 20210327; Test Name: troponin levels; Result Unstructured Data: Test Result:elevated
CDC Split Type: USPFIZER INC2021359715

Write-up: Chest Pain as a Result of Elevated Troponin Levels Caused by Myocarditis; Chest Pain as a Result of Elevated Troponin Levels Caused by Myocarditis; Chest Pain as a Result of Elevated Troponin Levels Caused by Myocarditis; This is a spontaneous report from Pfizer Sponsored Patient Support Program. A contactable consumer (patient) reported for himself that a 43-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6202), via an unspecified route of administration at the age of 43-year-old at arm left on 09Mar2021 14:00 at single dose for covid-19 immunisation. Medical history included high blood pressure. The patient wasn''t allergies to medications, food, or other products. Concomitant medications included metoprolol tartrate and vitamin D NOS. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6202) at left arm on 15Feb2021 6:00 PM for COVID-19 immunisation. The patient experienced chest pain as a result of elevated troponin levels caused by myocarditis on 27Mar2021 14:00. The events were serious for being hospitalized (duration 3 days). The adverse events result in Emergency room/department or urgent care. Facility where the most recent COVID-19 vaccine was administered in hospital. Prior to vaccination, the patient wasn''t diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests included nasal swab: negative on 29Mar2021. The patient was received treatment (Heparin, Nitroglycerin and Cardiac Catheterization) for events. The outcome of events was recovering.


VAERS ID: 1225732 (history)  
Form: Version 2.0  
Age: 16.0  
Sex: Male  
Location: Virginia  
Vaccinated:2021-04-15
Onset:2021-04-16
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP7534 / 1 UN / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN10162 / 2 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Blood creatinine normal, Blood urea normal, Chest pain, Fibrin D dimer increased, Haematocrit normal, Haemoglobin normal, Headache, Left ventricular dysfunction, Lymphocyte percentage decreased, Malaise, Monocyte percentage increased, Myalgia, Myocarditis, Neutrophil percentage increased, Platelet count normal, Pyrexia, SARS-CoV-2 test negative, Troponin I increased, White blood cell count increased
SMQs:, Rhabdomyolysis/myopathy (broad), Cardiac failure (broad), Haematopoietic leukopenia (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Multivitamin, Vitamin B12, and vitamin D
Current Illness: Had transient nausea and emesis following consumption of rare-cooked meat in early February, otherwise was well
Preexisting Conditions: Anxiety, depression, vitamin deficiency
Allergies: None
Diagnostic Lab Data: 4/18/21: WBC 13, Hgb 15, Hct 44, Plt count 298. 73% neutrophils, 17% lymphocytes, 9% monocytes. BUN 14, Creatinine 1. Troponin I 1.58 ng/mL. D-dimer 0.91 microg/mL. SARS-coronavirus 2 PCR from NP sampling negative.
CDC Split Type:

Write-up: On 4/16/21, the day after receipt of the second SARS-CoV-2 vaccine the patient developed new headache, fever, malaise, and myalagias. on 4/17/21 the patient then developed chest pain which worsened over time and lead to diagnosis of myocarditis with decreased left ventricle function of 44-47% and with troponin I of 1.58 ng/mL.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=5&SYMPTOMS=Myocarditis_%2810028606%29&VAX=COVID19&VAXTYPES=COVID-19&VAXMAN=PFIZER/BIONTECH


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166